These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6112116)

  • 21. [Monitored supportive treatment of chronic schizophrenia with delayed-action clopenthixol].
    Welbel L; Nurowska K; Szukalski B; Lipska B
    Psychiatr Pol; 1985; 19(2):109-14. PubMed ID: 4095213
    [No Abstract]   [Full Text] [Related]  

  • 22. A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients.
    Heikkilä L; Karsten D; Valli K
    Acta Psychiatr Scand Suppl; 1981; 294():25-9. PubMed ID: 7041516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
    Heikkilä L; Laitinen J; Vartiainen H
    Acta Psychiatr Scand Suppl; 1981; 294():30-8. PubMed ID: 7041517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
    Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
    Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic effect of zuclopenthixol acetate on positive and negative symptoms in schizophrenia].
    Szafrański T; Jarema M; Białek J; Buksowicz M; Marciniak E; Choma ME; Ruzikowska A; Milej M
    Psychiatr Pol; 1997; 31(1):55-69. PubMed ID: 9527656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cis(Z)-clopenthixol and clopenthixol in the treatment of acute psychoses and exacerbations of chronic psychoses. A double-blind clinical investigation.
    Gravem A; Bugge A
    Acta Psychiatr Scand Suppl; 1981; 294():13-24. PubMed ID: 7041515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels and clinical response in long-term pharmacotherapy with zuclopenthixol decanoate.
    Szukalski B; Lipska B; Welbel L; Nurowska K
    Psychopharmacology (Berl); 1986; 89(4):428-31. PubMed ID: 2875481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open clinical study of cis(Z)-clopenthixol.
    Sechter D; Caillard V; Cuche H; Deniker P
    Acta Psychiatr Scand Suppl; 1981; 294():20-4. PubMed ID: 6951393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cis(Z)-clopenthixol and clopenthixol (Sordinol) in chronic psychotic patients. A double-blind clinical investigation.
    Gravem A; Engstrand E; Guleng RJ
    Acta Psychiatr Scand; 1978 Nov; 58(5):384-8. PubMed ID: 362830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative trial of depot pipothiazine.
    Steinert J; Neder A; Erba E; Pugh CR; Robinson C; Priest RG
    J Int Med Res; 1986; 14(2):72-7. PubMed ID: 2870944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses.
    Fenton M; Coutinho ES; Campbell C
    Cochrane Database Syst Rev; 2000; (2):CD000525. PubMed ID: 10796549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zuclopenthixol acetate in Viscoleo--a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses.
    Amdisen A; Nielsen MS; Dencker SJ; Fensbo C; Ahlfors UG; Gravem A; Baastrup PC; Bjerkenstedt L; Gunby B; Wiesel FA
    Acta Psychiatr Scand; 1987 Jan; 75(1):99-107. PubMed ID: 2883816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients.
    Chakravarti SK; Muthu A; Muthu PK; Naik P; Pinto RT
    Curr Med Res Opin; 1990; 12(1):58-65. PubMed ID: 1971560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.
    Dencker SJ; Lepp M; Malm U
    Acta Psychiatr Scand Suppl; 1980; 279():64-76. PubMed ID: 6105763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics.
    Dencker SJ; Elgen K
    Acta Psychiatr Scand Suppl; 1980; 279():5-9. PubMed ID: 6996425
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
    Viala A; Ba B; Durand A; Gouezo F; Hou N; Jørgensen A
    Psychopharmacology (Berl); 1988; 94(3):293-7. PubMed ID: 2895936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depot perphenazine decanoate and enanthate for schizophrenia.
    Quraishi S; David A
    Cochrane Database Syst Rev; 2000; (2):CD001717. PubMed ID: 10796445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.
    Dencker SJ; Frankenberg K; Hansen V; Malm U
    Acta Psychiatr Scand Suppl; 1980; 279():29-40. PubMed ID: 6931471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients.
    Izmeth MG; Khan SY; Kumarajeewa DI; Shivanathan S; Veall RM; Wiley YV
    Pharmatherapeutica; 1988; 5(4):217-27. PubMed ID: 2902642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Findings with cis-Z-clopenthixol in the treatment of acute mania and schizophrenia.
    König P; Seifert T; Eberhardt G
    Pharmacopsychiatry; 1986 Nov; 19(6):424-8. PubMed ID: 3797470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.